Primary thyroid leiomyosarcoma, is extremely rare, with only 19 cases reported in the literature to date.
Introduction
In the current WHO (2004) classification of thyroid tumors, leiomyosarcoma was included, together with its benign counterpart leiomyoma, among the smooth muscle tumors of the thyroid gland. It is assumed that these tumors arise from degeneration of the smooth muscle of vessel walls of the gland.
Primary thyroid leiomyosarcoma is an extremely rare tumor, of which the literature reports only 19 cases [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] (see Table 1 ). Approximately 20% of sarcomas involve the head and neck region, affecting mainly the oral, subcutaneous soft tissues, lining of the sinuses and, rarely, the thyroid gland. Leiomyosarcomas account for only 0.014% of primary thyroid tumors. They usually develop in older subjects (mean age of known cases: 66 years) and show no correlation with gender. The development of distant metastases, mainly involving the lungs and liver, is a possibility in thyroid leiomyosarcoma, described in more than 50% of the cases reported in the literature to date (10/19).
When the tumor is confined to the thyroid the recommended surgical approach is total thyroidectomy with lymph node dissection. When the neoplasm invades surrounding structures, surgical approaches associated with radio and/or chemotherapy have not been found to improve prognosis at all. Survival is variable, ranging from 1 to 51 months, irrespective of the treatment undertaken [1, 8, 10] .
Authors experience
A white male patient, 80 years old, was referred to our hospital with a two-month history of gradual enlargement of the anterior neck. In the previous two weeks he had been experiencing dysphagia (difficult, not painful, swallowing) and dysphonia. He did not present Computed tomography showed a mass, measuring 8x5x7 cm, unevenly distributed in the left thyroid lobe and the presence of colloid cysts and calcified nodules.
The mass was causing compression and lateral displacement of the trachea and esophagus with no apparent signs of infiltration of these structures ( Fig. 1) There was no evidence of lung lesions. The patient underwent surgery which disclosed a tumor apparently involving only the left lobe of the thyroid. The thyroid capsule was intact.
During surgery, a fresh, left thyroid lobe specimen, consisting of a single fragment of hard, white tissue, 2 cm in diameter, was sent to pathology for intraoperative consultation. The intraoperative consultation diagnosis was: mesenchymal neoplasm, not otherwise specified.
The definitive diagnosis was deferred, pending examination of the permanent sections. A total thyroidectomy was planned and attempted, but during surgery it proved impossible to separate the mass from the left trachea and esophagus, to which it was tightly adherent. We decided to remove part of the mass for the purpose of decompression.
Subsequently, a left thyroid lobe specimen consisting of four fragments of hard, white tissue, ranging from 1.8 to 2.7 cm in diameter, were sent to pathology for the final diagnosis.
All submitted fragments were fixed in 10% neutral- deformed by the neoplastic fascicles (Fig. 2) . The Immunohistochemical studies play an important role in distinguishing UTCs from leiomyosarcomas. In two large series of UTC patients in which the AE1/AE3 cytokeratin antibody cocktail was used, cytokeratins were detected in about 80% of the cases [16, 17] . EMA was less commonly expressed (30-50%) [18] . Because some leiomyosarcomas have been shown to contain keratinpositive and/or EMA-positive cells, staining for these epithelial markers cannot be entirely relied upon to distinguish UTCs from leiomyosarcomas. This aberrant immunophenotype in leiomyosarcoma may be a potentially serious diagnostic problem.
In a comprehensive and systematic study, in which immunoreactivity for keratin and EMA was investigated in a large series of 100 leiomyosarcomas, positivity for cytokeratin and EMA was reported in 38% and 44% of the cases, respectively. Although the staining was usually focal, extensive immunoreactivity was observed in 11% with cytokeratin and 6% with EMA [19] . In our patient, the finding of diffuse positive myogenic marker staining coupled with absent expression of cytokeratins was a strong indication that the tumor was a leiomyosarcoma and, in view of the above considerations, the diffuse and strong immunoreactivity Generally, there is far more mitotic activity in leiomyosarcomas than in SETTLEs.
Immunohistochemically, the spindle cells in SETTLEs display diffuse immunoreactivity for cytokeratin; in rare cases, they may demonstrate myoepithelial cell differentiation with immunoreactivity for smooth muscle actin and for muscle-specific actin [20] . This phenomenon is a potential pitfall in the differential diagnosis. In our case, a diagnosis of SETTLE was excluded on the basis of the absence of a biphasic pattern, cytokeratin expression and a lobulated pattern.
Moreover, the patient's age was not consistent with a SETTLE.
Traditionally, the differential diagnosis of leiomyosarcomas includes other sarcomas that consist of fascicles of moderately differentiated spindle cells such as fibrosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumor.
Usually, a correct diagnosis can be assigned based on a combination of histologic appearances, patterns of protein expression, assessed by immunohistochemistry, and clinical findings.
Conclusion
In conclusion, primary leiomyosarcoma of the thyroid is a challenging condition requiring close collaboration between radiologist, pathologist and surgeon.
Unfortunately, efforts to overcome the difficulties encountered in the differential diagnosis and subsequent therapeutic approaches are undermined by the very poor short-term prognosis linked to the extreme aggressiveness of the tumor.
